Back
BeiGene Vs. Leap Therapeutics Industry Stock Comparison
Sell
30
BGNE
BeiGene
Last Price:
147.13
Seasonality Move:
18.09%
Buy
57
LPTX
Leap Therapeutics
Last Price:
3.20
Seasonality Move:
-5.87%
Sell
30
BeiGene (BGNE)
is a Sell
Is BeiGene a Buy, Sell or Hold?
- The current BeiGene [BGNE] share price is $144.12. The Score for BGNE is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- BGNE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
57
Leap Therapeutics (LPTX)
is a Buy
Is Leap Therapeutics a Buy, Sell or Hold?
- The current Leap Therapeutics [LPTX] share price is $3.29. The Score for LPTX is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- LPTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BGNE Stock Price Chart
LPTX Stock Price Chart
What is Leap Therapeutics's stock price today?
-
The Leap Therapeutics share price today is $3.29
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LPTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
BGNE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -6.09 | Sell |
| Relative Strength Index (14 RSI): | 47.65 | Sell |
| Chaikin Money Flow: | 11651 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (137.13 - 157.95) | Sell |
| Bollinger Bands (100): | (147.02 - 177.02) | Sell |
LPTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.13 | Buy |
| Relative Strength Index (14 RSI): | 60.67 | Buy |
| Chaikin Money Flow: | 174442 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.53 - 3.13) | Buy |
| Bollinger Bands (100): | (2.47 - 3.55) | Buy |
BGNE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 134.99 | Buy |
| 20-day SMA: | 144.77 | Sell |
| 50-day SMA: | 154.32 | Sell |
| 200-day SMA: | 176.62 | Sell |
| 8-day EMA: | 138.08 | Buy |
| 20-day EMA: | 143.57 | Buy |
| 50-day EMA: | 152.01 | Sell |
| 200-day EMA: | 173.89 | Sell |
LPTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.05 | Buy |
| 20-day SMA: | 2.91 | Buy |
| 50-day SMA: | 2.77 | Buy |
| 200-day SMA: | 2.51 | Buy |
| 8-day EMA: | 3.09 | Buy |
| 20-day EMA: | 2.94 | Buy |
| 50-day EMA: | 2.86 | Buy |
| 200-day EMA: | 3.22 | Buy |
BeiGene Earnings Growth & BGNE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.91 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.01 per share, and an increase next year of $4.90 per share.
Leap Therapeutics Earnings Growth & LPTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.26 per share, an increase this year of $1.00 per share, and an increase next year of $0.91 per share.
BeiGene Technical Analysis
| Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Leap Therapeutics Technical Analysis
| Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||